- Home
- GPN vs DGX Comparison
GPN vs DGX Comparison
Compare GPN & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPN
- DGX
- Stock Information
- Founded
- GPN 1967
- DGX 1967
- Country
- GPN United States
- DGX United States
- Employees
- GPN N/A
- DGX N/A
- Industry
- GPN Business Services
- DGX Medical Specialities
- Sector
- GPN Consumer Discretionary
- DGX Health Care
- Exchange
- GPN Nasdaq
- DGX Nasdaq
- Market Cap
- GPN 20.6B
- DGX 20.5B
- IPO Year
- GPN 2001
- DGX 1996
- Fundamental
- Price
- GPN $72.34
- DGX $186.45
- Analyst Decision
- GPN Buy
- DGX Buy
- Analyst Count
- GPN 22
- DGX 15
- Target Price
- GPN $103.20
- DGX $194.07
- AVG Volume (30 Days)
- GPN 2.3M
- DGX 1.2M
- Earning Date
- GPN 11-04-2025
- DGX 10-21-2025
- Dividend Yield
- GPN 1.38%
- DGX 1.72%
- EPS Growth
- GPN 34.30
- DGX 14.49
- EPS
- GPN 7.12
- DGX 8.51
- Revenue
- GPN $10,076,185,000.00
- DGX $10,850,000,000.00
- Revenue This Year
- GPN N/A
- DGX $12.37
- Revenue Next Year
- GPN $5.66
- DGX $3.51
- P/E Ratio
- GPN $10.20
- DGX $21.87
- Revenue Growth
- GPN 22.33
- DGX 13.74
- 52 Week Low
- GPN $65.93
- DGX $148.70
- 52 Week High
- GPN $120.00
- DGX $197.55
- Technical
- Relative Strength Index (RSI)
- GPN 29.56
- DGX 54.66
- Support Level
- GPN $74.88
- DGX $185.09
- Resistance Level
- GPN $78.48
- DGX $189.26
- Average True Range (ATR)
- GPN 2.35
- DGX 4.20
- MACD
- GPN -0.55
- DGX 0.82
- Stochastic Oscillator
- GPN 6.03
- DGX 64.21
About GPN Global Payments Inc.
Global Payments is a leading provider of payment processing and software solutions and focuses on serving small and midsize merchants. The company operates in 30 countries and generates about one fourth of its revenue from outside North America, primarily in Europe and Asia. In 2019, Global Payments merged with Total System Services in an all-stock deal that gave Total System Services shareholders 48% of the combined company's shares. The merger added issuer processing operations.
About DGX Quest Diagnostics Incorporated
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.